Back to all papers

Multiparametric 0.4-T low-field MRI mapping for metabolic dysfunction-associated steatotic liver disease in rats.

November 14, 2026pubmed logopapers

Authors

Okumura K,Yamauchi H,Kozaka K,Ohno N,Kitao A,Yamashita T,Harada K,Takeshita Y,Takamura T,Kobayashi S

Affiliations (6)

  • Department of Radiology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
  • Faculty of Health Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
  • Department of Radiology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan. [email protected].
  • Department of Gastroenterology, Graduate School of Medical Sciences, Kanazawa, Japan.
  • Department of Human Pathology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
  • Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.

Abstract

Low-field MRI may broaden access to quantitative liver imaging, but low signal-to-noise ratio and coexisting steatosis, inflammation, fibrosis, and iron complicate relaxometry in metabolic dysfunction-associated steatotic liver disease (MASLD). We evaluated multiparametric 0.4-T MRI with deep-learning-reconstructed T1 mapping in rats. In this prospective cross-sectional preclinical study, 90 male Wistar rats underwent 0.4-T liver MRI during dietary induction, progression, and recovery. Metrics included native T1, fat-corrected T1 (FcT1), T2, T2<sup>*</sup>, and an apparent proton density fat fraction (PDFF) estimate. Whole-section digital pathology quantified steatosis, fibrosis, inflammation, and iron. Associations were assessed using iron-adjusted and stage-aware analyses, multivariable regression with variance inflation factors, and receiver operating characteristic analysis. Steatosis strongly correlated with T2 (ρ = 0.90, p < 0.001) and PDFF (ρ = 0.88, p < 0.001). For high inflammation, T2 and T2<sup>*</sup> yielded areas under the curve (AUROCs) of 0.86 (95% confidence interval 0.78-0.94) and 0.80 (0.71-0.89), respectively (p = 0.294); specificities were 82.2% and 91.1%, respectively. For fibrosis, native T1 yielded higher AUROCs than FcT1 at collagen proportionate area (CPA) > 2.42% (0.77 versus 0.62; p = 0.008) and > 2.90% (0.78 versus 0.60; p = 0.001). Stage-aware analyses attenuated T1-fibrosis associations, and recovery animals showed residual fibrosis with near-baseline T1. Multiparametric 0.4-T MRI showed complementary, partly stage-dependent associations with MASLD pathology. T2/PDFF tracked steatosis; T2<sup>*</sup> retained an inflammation-related association after stage adjustment; and T1 elevation characterized active high-burden progression rather than isolated residual fibrosis. Human validation and platform calibration are required. Question Noninvasive MASLD assessment needs accessible imaging biomarkers that account for coexisting steatosis, inflammation, fibrosis, and iron-related confounding in liver MRI. Findings Multiparametric 0.4-T MRI showed complementary but stage-dependent associations: T2/apparent PDFF tracked steatosis, T2<sup>*</sup> related to inflammation, and T1 rose during high-burden progression. Relevance statement Multiparametric 0.4-T MRI provides complementary pathology-correlated measurements for MASLD assessment in rats, but reconstruction-dependent T1 bias and apparent PDFF estimation require platform calibration and human validation before clinical interpretation.

Topics

Fatty LiverMagnetic Resonance ImagingMultiparametric Magnetic Resonance ImagingNon-alcoholic Fatty Liver DiseaseJournal Article

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAISlice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.